FIELD: medicine.
SUBSTANCE: group of inventions relates to medicine, namely to therapy and can be applied in treatment of group of mitochondrial malfunctions or risk of such malfunction appearance. Methods by invention include introduction of formula I compounds which represent pyrimidine-based nucleosides.
EFFECT: methods ensure reduction of clamed malfunctions manifestations due to correction of processes in synthetic path of pyrimidines.
20 cl, 1 tbl, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR TREATING MITOCHONDRIAL DISORDERS | 2000 |
|
RU2268732C2 |
| COMPOSITION AND METHOD FOR TREATING PATIENTS FOR MITOCHONDRIAL DISEASES | 1999 |
|
RU2279880C2 |
| 2',3'-DIACETYLURIDINE SUBSTITUTED WITH ACETOACETYL IN 5' POSITION | 2021 |
|
RU2839363C1 |
| DERIVATIVES OF 3-(6-CHLORO-3-OXO-3.4-DIHYDRO-(2H)-1.4-BENZOXASIN-4-YL)PROPIONIC ACID AND THEIR USE AS KMO INHIBITORS | 2016 |
|
RU2746001C2 |
| TREATMENT OF MITOCHONDRIAL DISEASES | 2016 |
|
RU2745611C2 |
| COMPOUNDS USED FOR SLEEP/WAKEFULNESS CYCLE NORMALISATION | 2003 |
|
RU2366428C2 |
| TREATMENT OF MITOCHONDRIAL DISEASES | 2016 |
|
RU2834339C1 |
| METALLOPORPHYRIN TREATMENT OF NEUROLOGICAL DISEASES | 2012 |
|
RU2623207C2 |
| DEOXYNUCLEOSIDE THERAPY OF DISEASES CAUSED BY UNBALANCED NUCLEOTIDE POOLS, INCLUDING MITOCHONDRIAL DNA DEPLETION SYNDROMES | 2016 |
|
RU2721492C2 |
| METHOD OF BLOOD PRESSURE REDUCTION IN PRE-HYPERTENSIVE INDIVIDUALS AND/OR IN INDIVIDUALS HAVING METABOLIC SYNDROME | 2006 |
|
RU2427382C2 |
